By Kristina Torfgard (IRLAB Therapeutics)2024-09-05T10:00:08
Introducing Kristina Torfgard! Holding a PhD in Clinical Pharmacology, she has over 30 years’ experience in drug development and is currently CEO of IRLAB Therapeutics.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-17T09:14:00Z
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2026-05-05T13:24:00
Sponsored by HUB Organoids
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-03-08T10:00:25
Sponsored by Molecular Devices
Site powered by Webvision Cloud